기관회원 [로그인]
소속기관에서 받은 아이디, 비밀번호를 입력해 주세요.
개인회원 [로그인]

비회원 구매시 입력하신 핸드폰번호를 입력해 주세요.
본인 인증 후 구매내역을 확인하실 수 있습니다.

회원가입
서지반출
Role of Transforming Growth Factor-β in Tumor Invasion and Metastasis
[STEP1]서지반출 형식 선택
파일형식
@
서지도구
SNS
기타
[STEP2]서지반출 정보 선택
  • 제목
  • URL
돌아가기
확인
취소
  • Role of Transforming Growth Factor-β in Tumor Invasion and Metastasis
  • Role of Transforming Growth Factor-β in Tumor Invasion and Metastasis
저자명
Kim. Eun-Sook,Moon. Aree
간행물명
Journal of toxicology and public health : an official journal of the Korean Society of Toxicology
권/호정보
2007년|23권 3호|pp.197-205 (9 pages)
발행정보
한국독성학회
파일정보
정기간행물|ENG|
PDF텍스트
주제분야
기타
이 논문은 한국과학기술정보연구원과 논문 연계를 통해 무료로 제공되는 원문입니다.
서지반출

기타언어초록

Cancer metastasis is a major determinant of cancer patient mortality. Mounting evidence favors a strong positive role for $TGF-{eta}$ in human cancer progression. The complex pattern on cross-talk of $TGF-{eta}$ and the related other signaling pathways is an important area of investigation that will ultimately contribute to understanding of the bifunctional role of $TGF-{eta}$ in cancer progression. This review summarizes some of the current understanding of $TGF-{eta}$ signaling with a major focus in its contribution to the tumor cell invasion and metastasis. Five issues are addressed in this review: (1) $TGF-{eta}$ signaling, (2) $TGF-{eta}$ and EMT, (3) $TGF-{eta}$ and MMP, (4) $TGF-{eta}$ and Ras, and (5) Role of $TGF-{eta}$ in invasion and metastasis. Due to the bifunctional cellular effects of $TGF-{eta}$, as a tumor promoter and a tumor suppressor, more precisely defined $TGF-{eta}$ signaling pathways need to be elucidated. According to the current literature, $TGF-{eta}$ is clearly a major factor stimulating tumor progression through a complex spectrum of the interplay and cross-talk between various signaling molecules. Understanding the role of $TGF-{eta}$ in invasion and metastasis will provide valuable information on establishing strategies to manipulate $TGF-{eta}$ signaling which should be a high priority for the development of anti-metastatic therapeutics.